The effect of CYP1A induction on amiodarone disposition in the rat

Journal of Pharmaceutical Sciences

Volumn 99, Issue 1, 2010, Pages 539-548

  Elsherbiny, Marwa E ^a   Brocks, Dion R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Clearance; CYP enzymes; Distribution; Induction; Metabolism; Pharamcokinetics; Phase I enzyme

Indexed keywords

AMIODARONE; BETA NAPHTHOFLAVONE; CYTOCHROME P450 1A; DEETHYLAMIODARONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISPOSITION; MALE; NONHUMAN; RAT;

EID: 73949104716     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21841     Document Type: Article

References (52)

1. Naccarelli GV, Wolbrette DL, Dell'Orfano JT, Patel HM, Luck JC. 2000. Amiodarone: What have we learned from clinical trials? Clin Cardiol 23:73-82.
2. Holt DW, Tucker GT, Jackson PR, Storey GC. 1983. Amiodarone pharmacokinetics. Am Heart J 106:840-847.
3. Brien JF, Jimmo S, Brennan FJ, Ford SE, Armstrong PW. 1987. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. Can J Physiol Pharmacol 65:360-364.
4. Shayeganpour A, Hamdy DA, Brocks DR. 2008. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone. Biopharm Drug Dispos 29:159-166.
5. Debbas NM, du Cailar C, Bexton RS, Demaille JG, Camm AJ, Puech P. 1984. The QT interval: A predictor of the plasma and myocardial concentrations of amiodarone. Br Heart J 51:316-320.
6. Connolly SJ, Latini R, Kates RE. 1984. Pharmacodynamics of intravenous amiodarone in the dog. J Cardiovasc Pharmacol 6:531-535.
7. Young RA, Mehendale HM. 1986. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine. Drug Metab Dispos 14:423-429.
8. Trivier JM, Libersa C, Belloc C, Lhermitte M. 1993. Amiodarone N-deethylation in human liver microsomes: Involvement of cytochrome P450 3A enzymes (first report). Life Sci 52:PL91-PL96.
9. Fabre G, Julian B, Saint-Aubert B, Joyeux H, Berger Y. 1993. Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Drug Metab Dispos 21:978-985.
10. Latini R, Reginato R, Burlingame AL, Kates RE. 1984. High-performance liquid chromatographic isolation and fast atom bombardment mass spectrometric identification of Di-N-desethylamiodarone, a new metabolite of amiodarone in the dog. Biomed Mass Spectrom 11:466-471.
11. Stark G, Stark U, Windisch M, Vicenzi M, Eggenreich U, Nagl S, Kral K, Pilger E, Tritthart HA. 1991. Comparison of acute electrophysiological effects of amiodarone and its metabolite desethylamiodarone in Langendorff perfused guinea pig hearts. Basic Res Cardiol 86:136-147.
12. Massey TE, Leeder RG, Rafeiro E, Brien JF. 1995. Mechanisms in the pathogenesis of amiodaroneinduced pulmonary toxicity. Can J Physiol Pharmacol 73:1675-1685.
13. Meng X, Mojaverian P, Doedee M, Lin E, Weinryb I, Chiang ST, Kowey PR. 2001. Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Am J Cardiol 87:432-435.
14. Kannan R, Sarma JS, Guha M, Venkataraman K. 1989. Tissue drug accumulation and ultrastructural ultrastructural changes during amiodarone administration in rats. Fundam Appl Toxicol 13:793-803.
15. Kharidia J, Eddington ND. 1996. Effects of desethylamiodarone on the electrocardiogram in conscious freely moving animals: Pharmacokinetic and pharmacodynamic modeling using computer-assisted radio telemetry. Biopharm Drug Dispos 17:93-106.
16. Nattel S. 1986. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite. J Cardiovasc Pharmacol 8:771-777.
17. Camus P, Martin WJ II, Rosenow EC III. 2004. Amiodarone pulmonary toxicity. Clin Chest Med 25:65-75.
18. Pollak PT. 1999. Clinical organ toxicity of antiarrhythmic compounds: Ocular and pulmonary manifestations. Am J Cardiol 84:37R-45R.
19. Ohyama K, Nakajima M, Nakamura S, Shimada N, Yamazaki H, Yokoi T. 2000. A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: An approach to predict the contribution with relative activity factor. Drug Metab Dispos 28:1303-1310.
20. Elsherbiny ME, El-Kadi AO, Brocks DR. 2008. The metabolism of amiodarone by various CYP isoenzymes of human and rat, and the inhibitory influence of ketoconazole. J Pharm Pharm Sci 11:147-159.
21. Shayeganpour A, El-Kadi AO, Brocks DR. 2006. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: The contribution of cytochrome P450 3A isoforms. Drug Metab Dispos 34:43-50.
22. Wheeler CW, Park SS, Guenthner TM. 1990. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes. Mol Pharmacol 38:634-643.
23. Pasanen M, Stenback F, Park SS, Gelboin HV, Pelkonen O. 1988. Immunohistochemical detection of human placental cytochrome P-450-associated mono-oxygenase system inducible by maternal cigarette smoking. Placenta 9:267-275.
24. Petruzzelli S, Camus AM, Carrozzi L, Ghelarducci L, Rindi M, Menconi G, Angeletti CA, Ahotupa M, Hietanen E, Aitio A, Saracci R, Bartsch H, Giuntini C. 1988. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: A casecontrol study on lung cancer patients. Cancer Res 48:4695-4700.
25. Thum T, Erpenbeck VJ, Moeller J, Hohlfeld JM, Krug N, Borlak J. 2006. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 114:1655-1661.
26. Bargout R, Jankov A, Dincer E, Wang R, Komodromos T, Ibarra-Sunga O, Filippatos G, Uhal BD. 2000. Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 278:L1039-1044.
27. Shayeganpour A, Jun AS, Brocks DR. 2005. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models. Biopharm Drug Dispos 26:249-257.
28. Sinal CJ, Webb CD, Bend JR. 1999. Differential in vivo effects of alpha-naphthoflavone and betanaphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney. J Biochem Mol Toxicol 13:29-40.
29. Brown JP, Dietrich PS. 1979. Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: Activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat Res 66:223-240.
30. Anderson LM, Priest LJ, Deschner EE, Budinger JM. 1983. Carcinogenic effects of intracolonic benzo[ a]pyrene in beta-naphthoflavone-induced mice. Cancer Lett 20:117-123.
31. Poland A, Knutson JC. 1982. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22:517-554.
32. Shayeganpour A, Somayaji V, Brocks DR. 2007. A liquid chromatography-mass spectrometry assay method for simultaneous determination of amiodarone and desethylamiodarone in rat specimens. Biomed Chromatogr 21:284-290.
33. Bailer AJ. 1988. Testing for the equality of area under the curves when using destructive measurement techniques. J Pharmacokinet Biopharm 16:303-309.
34. Anonymous. 2007. The Top Ten Causes of Death. WHO, Fact sheet No 310.
35. Mason JW. 1987. Amiodarone. N Engl J Med 316:455-466.
36. Anonymous. 2005. WHO Pharmaceuticals Newsletter, No. 1.
37. Anonymous. 2005. WHO Pharmaceuticals Newsletter, No. 2.
38. Denison MS, Heath-Pagliuso S. 1998. The Ah receptor: A regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull Environ Contam Toxicol 61:557-568.
39. Anonymous. 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoking and tobacco smoke. 83.
40. Lupp A, Danz M, Muller D. 2001. Morphology and cytochrome P450 isoforms expression in precisioncut rat liver slices. Toxicology 161:53-66.
41. Lupp A, Danz M, Muller D. 2005. Histomorphological changes and cytochrome P450 isoforms expression and activities in precision-cut liver slices from neonatal rats. Toxicology 206:427-438.
42. Stresser DM, Bailey GS, Williams DE. 1994. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Drug Metab Dispos 22:383-391.
43. Brunner LJ, Bai S. 2000. Effect of dietary oil intake on hepatic cytochrome P450 activity in the rat. J Pharm Sci 89:1022-1027.
44. Okayasu K, Takeda Y, Kojima J, Yoshizawa A, Kobayashi N, Sugiyama H, Kudo K. 2006. Amiodarone pulmonary toxicity: A patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. Intern Med 45:1303-1307.
45. Ashrafian H, Davey P. 2001. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 120:275-282.
46. Ernawati DK, Stafford L, Hughes JD. 2008. Amiodarone-induced pulmonary toxicity. Br J Clin Pharmacol 66:82-87.
47. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
48. Guengerich FP, Dannan GA, Wright ST, Martin MV, Kaminsky LS. 1982. Purification and characterization of liver microsomal cytochromes p-450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry 21:6019-6030.
49. Xu L, Li AP, Kaminski DL, Ruh MF. 2000. 2,3,7,8 Tetrachlorodibenzo-p- dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes. Chem Biol Interact 124:173-189.
50. de Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH. 1990. Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387-394.
51. Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng YF, Guengerich FP, Inui Y. 1996. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 24:515-522.
52. Paine MF, Schmiedlin-Ren P, Watkins PB. 1999. Cytochrome P-450 1A1 expression in human small bowel: Interindividual variation and inhibition by ketoconazole. Drug Metab Dispos 27:360-364.